Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Routine dental checkups offer opportunity to observe changes in patient’s health

Routine dental checkups offer opportunity to observe changes in patient’s health

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Xenotransplantation – organ transplants from animals may soon be a reality

Xenotransplantation – organ transplants from animals may soon be a reality

Researchers boost antimicrobial and anticancer properties of spider peptides

Researchers boost antimicrobial and anticancer properties of spider peptides

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Shaping the future of oncology treatment

Shaping the future of oncology treatment

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

DKFZ scientists reveal how cancer cells suppress immune system to spread and multiply

DKFZ scientists reveal how cancer cells suppress immune system to spread and multiply

Expanding clinical flow cytometry portfolio unveiled by Beckman Coulter at AACC

Expanding clinical flow cytometry portfolio unveiled by Beckman Coulter at AACC

Gene editing technology shines light on rare dyskeratosis congenita

Gene editing technology shines light on rare dyskeratosis congenita

New approach may improve translation of immunological research findings

New approach may improve translation of immunological research findings

Wayne State researchers receive $1.9 million NIH grant to better understand rare genetic disorders

Wayne State researchers receive $1.9 million NIH grant to better understand rare genetic disorders

New genomic research partnership promises to redefine and transform cancer treatment

New genomic research partnership promises to redefine and transform cancer treatment

New analysis compares emerging algorithms that look for cancer mutations

New analysis compares emerging algorithms that look for cancer mutations

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance